Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
1.830
+0.040 (2.23%)
At close: Dec 31, 2025, 4:00 PM EST
1.781
-0.049 (-2.69%)
After-hours: Dec 31, 2025, 7:04 PM EST
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $51.21 million as of December 31, 2025. Its market cap has decreased by -83.43% in one year.
Market Cap
51.21M
Enterprise Value
2.01M
1-Year Change
-83.43%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $51.21M, a decrease of -58.28%. That is a compound annual growth rate of -13.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 51.21M | -84.03% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |